Drew Watson

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Unsupervised Deep Representation Learning and Probabilistic Clustering for the Systems-Level Discovery of Germline Mutation Signatures in Pediatric Cancers

  Biomedicines · 2026-06-24

• A novel serum-based multi-omic machine learning model improves early detection of ovarian cancer in the symptomatic population

  Gynecologic Oncology · 2026-04-23

• Abstract 2449: Comparison of liquid versus solid tissue genomic profiling for the prediction of chemo-immunotherapy benefit in advanced NSCLC

  Cancer Research · 2026-04-03

• Abstract 5252: Computational modeling of comprehensive genomic profiling to predict chemo-immunotherapy benefit in early stage NSCLC

  Cancer Research · 2026-04-03

• Development and validation of computational histology artificial intelligence (CHAI)–powered prognostic and predictive biomarkers in metastatic hormone-sensitive prostate cancer (mHSPC) using ENZAMET and CHAARTED prospective randomized phase 3 trials (RCT).

  Journal of Clinical Oncology · 2026-03-01

• Development and Validation of a Computational Histology Artificial Intelligence–Powered Predictive Biomarker for Selection of Chemotherapy in Advanced Pancreatic Cancer

  Journal of Clinical Oncology · 2026-02-11 · 1 citations

• 24 Identification of genomic aberrations contributing to the prediction of chemotherapy benefit in advanced NSCLC

  Regular and Young Investigator Award Abstracts · 2025-11-01

• Use of an Integrative Genomics Approach to Identify Metastatic NSCLC Patients Benefiting From the Addition of Chemotherapy to Immune Checkpoint Inhibitors

  Clinical Lung Cancer · 2025-10-30

• P2.06.18 Computational Modeling of Comprehensive Genomic Profiling to Predict Chemotherapy Benefit in Advanced NSCLC

  Journal of Thoracic Oncology · 2025-10-01

• Implementation of <i>DPYD</i> and <i>UGT1A1</i> Testing in Patients With GI Cancer: A Prospective, Nonrandomized Clinical Trial

  JCO Precision Oncology · 2025-08-01 · 4 citations

• Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non–muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification Schemes

  European Urology · 2025-06-12 · 7 citations

• Mo1185: A PROBABILISTIC MODEL LEVERAGING BLOOD-BASED MULTIMODAL BIOMARKERS CORRELATED WITH INDEX LESION SIZE, SUMBER, AND DEGREE OF DYSPLASIA WITH IMPROVED SENSITIVITY OF ADVANCED ADENOMAS

  Gastroenterology · 2025-05-01

• Presence of an Artificial Intelligence–powered Predictive Biomarker Is Associated with a Poor Response to Intravesical Bacillus Calmette-Guerin but Not to Intravesical Sequential Gemcitabine/Docetaxel in Patients with High-grade Non–muscle-invasive Bladder Cancer

  European Urology Oncology · 2025-04-25 · 5 citations

• Abstract 7064: Minimally invasive detection of advanced adenomas in colorectal cancer screening through circulating epithelial cells and somatic DNA aberrations

  Cancer Research · 2025-04-21

• PD12-10 AN ARTIFICIAL INTELLIGENCE-POWERED PREDICTIVE BIOMARKER FOR RESPONSE TO INTRAVESICAL BCG VERSUS GEMCITABINE-DOCETAXEL FOR HIGH-GRADE NON-MUSCLE INVASIVE BLADDER CANCER

  The Journal of Urology · 2025-04-08

• Integration of GWAS, QTLs and keratinocyte functional assays reveals molecular mechanisms of atopic dermatitis

  Nature Communications · 2025-04-01 · 13 citations

• AN ARTIFICIAL INTELLIGENCE-POWERED MODEL TO PREDICT RESPONSE TO INTRAVESICAL BCG VERSUS GEMCITABINE-DOCETAXEL FOR HIGH-RISK NON-MUSCLE INVASIVE BLADDER CANCER

  Urologic Oncology Seminars and Original Investigations · 2025-02-27

• Predicting Response to Intravesical BCG in High-Risk NMIBC Using an Artificial Intelligence–Powered Pathology Assay: Development and Validation in an International 12-Center Cohort

  The Journal of Urology · 2024-10-09 · 5 citations

• MA09.06 Use of Biosimulation to Predict Chemotherapy Benefit in Patients with Metastatic NSCLC Being Treated with Immunotherapy

  Journal of Thoracic Oncology · 2024-10-01